NCT05634057View on ClinicalTrials.gov

Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis

NARecruitingINTERVENTIONAL
Enrollment

782

Participants

Timeline

Start Date

January 25, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Sepsis
Interventions
DRUG

Anisodamine hydrobromide combined with heparin

The anisodamine hydrobromide combined with heparin treatment group is on the basis of conventional treatment.

Trial Locations (1)

100020

RECRUITING

Beijing Chaoyang Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Chen Ying

OTHER